脏辅酶A (CoA) 生产燃料 干细胞增殖和瘤生长
Ting Miao1, Ying Liu1, Mujeeb Qadiri1
1Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
bioRxiv : the preprint server for biology
|August 20, 2025
概括
饮食维生素B5促进了飞脏中的辅酶A的产生,影响了肠道健康和干细胞生长. 这种由Myc驱动的肠回路会影响瘤的发展和癌症的结果.
科学领域:
- 代谢调节 代谢调节 代谢调节
- 器官间的信号传输
- 发育生物学是发展生物学.
背景情况:
- 由维生素B5 (VB5) 衍生出来的辅酶A (CoA) 对细胞代谢至关重要,但其系统性作用和组织特异性调节尚不清楚.
- 了解CoA在细胞内途径之外的生理功能对于代谢和癌症研究至关重要.
研究的目的:
- 研究辅酶A (CoA) 的组织特异性调节和系统生理作用.
- 揭示肠回路在调解CoA对恒温和增殖的影响中的作用.
主要方法:
- 使用 *Drosophila melanogaster* (果) 作为一个模型生物.
- 通过基因表达分析 (调高*Fbl*,降低*dPANK4*) 调查了Myc在调节脏CoA生物合成中的作用.
- 评估了增强的CoA生产对美酸盐-异oprenoid通路和肠道干细胞增殖的影响.
主要成果:
- 发现了一种肠回路,其中饮食VB5刺激的CoA生物合成马尔皮希亚管 (MTs),影响肠道平衡.
- Myc在MT中直接调高*Fbl*和调低*dPANK4*,从而促进脏的CoA产生.
- 脏CoA的升高增强了肠道美瓦隆酸-异烯酸路径的活性,促进了肠道干细胞的增殖和肠道瘤的生长.
结论:
- Myc驱动的CoA代谢建立了一个器官间信号,将VB5的可用性与干细胞控制和瘤生长联系起来.
- CoA-异oprenoid轴被确定为癌症中的关键代谢脆弱性,对人类癌症的结果有影响.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K


